{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06074380",
            "orgStudyIdInfo": {
                "id": "EH23-232"
            },
            "organization": {
                "fullName": "NorthShore University HealthSystem",
                "class": "OTHER"
            },
            "briefTitle": "Non Inferiority Trial Investigating Surfactants Administered Via MIST",
            "officialTitle": "Non Inferiority Trial Investigating Surfactants Administered Via MIST",
            "acronym": "Niftisurf",
            "therapeuticArea": [
                "Respiratory"
            ],
            "study": "non-inferiority-trial-investigating-surfactants-administered-via-mist"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-01-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-12-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-09-27",
            "studyFirstSubmitQcDate": "2023-09-27",
            "studyFirstPostDateStruct": {
                "date": "2023-10-10",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-28",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Matthew Derrick",
                "investigatorTitle": "Attending Neonatologist",
                "investigatorAffiliation": "NorthShore University HealthSystem"
            },
            "leadSponsor": {
                "name": "NorthShore University HealthSystem",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "RESEARCH DESIGN Multicenter, randomized, controlled trial. RECRUITMENT Entry criteria Preterm infants 28-35 6/7 weeks' gestation and less than 48 hours of age who have a clinical diagnosis of respiratory distress syndrome. Infants who are on NCPAP and FiO2 \u22650.30 will randomized to curosurf or infasurf via MIST.\n\nExclusion criteria Infants will be excluded if there is a congenital anomaly or an alternative cause for respiratory distress.\n\nBabies who require emergent intubation will not be enrolled in the interventions.\n\nParental Consent will be obtained prior to randomization.",
            "detailedDescription": "INTERVENTION Infants who on CPAP who reach the threshold of 30% oxygen will be randomized to calfactant (Infasurf), 3ml/kg or poractant alfa (Curosurf), 2.5ml/kg, administered under direct laryngoscopy using a surfactant instillation catheter (MIST) 16G Angiocath (Becton Dickinson, Sandy, UT, USA).\n\nA second dose of calfactant (Infasurf) 3ml/kg or poractant alfa (Curosurf), 1.25ml/kg, will be administered via MIST their fiO2 reaches the threshold of 30% between 6 and 48 hours after the first dose.\n\nNo further surfactant should be given in the first 7 days unless the infant reaches the intubation criteria.\n\nPOST-INTERVENTION MANAGEMENT Other than the requirement to adhere to intubation criteria in the first week, and in some cases perform a room air trial at 36 weeks corrected gestation, management will be at the discretion of the clinical team.\n\nTitration of CPAP pressure is encouraged, with a permitted maximum of 8 cm H2O. Use of nasal IPPV is allowable for apnea, but discouraged for RDS and should only be after at least one dose of surfactant has been given. Early caffeine therapy is expected.\n\nCriteria for intubation:\n\nEnrolled infants on CPAP will be intubated if:\n\n* FiO2 \u22650.45 for 15 minutes, or if there is unremitting apnea (\\> 6 episodes/hour requiring intervention or in the opinion of the treating physician) or persistent respiratory acidosis (pH\\<7.25 and pCO2 \\>60) on blood gasses at least 30 minutes apart or metabolic acidosis refractory to treatment.\n* Need for an anesthetic or an intervention requiring intubation\n\nThese criteria apply during the first week of life, and to the first episode of intubation only. If the infant is intubated it is expected that another dose of surfactant will be administered."
        },
        "conditionsModule": {
            "conditions": [
                "Respiratory Distress Syndrome"
            ],
            "keywords": [
                "Pulmonary Surfactant",
                "CPAP",
                "Neonate"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Comparison of the efficacy of calfactant compared to poractant alfa administered with a minimally invasive method for the treatment of respiratory distress syndrome in 28-36 week infants",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "maskingDescription": "Surfactant will be sent from Investigational Pharmacy",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 262,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Calfactant (Infasurf)",
                    "type": "EXPERIMENTAL",
                    "description": "Neonate, 28-35 weeks gestation, less than 48 hours of age, with respiratory distress syndrome on CPAP \\> 30% oxygen will be given 3ml/kg of Calfacant",
                    "interventionNames": [
                        "Drug: MIST surfactant"
                    ]
                },
                {
                    "label": "Poractant alfa (Curosurf)",
                    "type": "EXPERIMENTAL",
                    "description": "Neonate, 28-35 weeks gestation, less than 48 hours of age, with respiratory distress syndrome on CPAP \\> 30% oxygen will be given 2.5ml/kg of Poractant alfa.",
                    "interventionNames": [
                        "Drug: MIST surfactant"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "MIST surfactant",
                    "description": "Surfactant will be given via MIST while neonate is on CPAP",
                    "armGroupLabels": [
                        "Calfactant (Infasurf)",
                        "Poractant alfa (Curosurf)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of infants requiring Endotracheal Intubation",
                    "description": "Infants will have an endotracheal placed if their inspired oxygen is \\>45% for more than 15 minutes",
                    "timeFrame": "7 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Duration of positive pressure support",
                    "description": "Endotracheal ventilation or Non-invasive Ventilation or CPAP or NC flow\\>2 L",
                    "timeFrame": "36 weeks corrected gestational age"
                },
                {
                    "measure": "Duration of Supplemental oxygen",
                    "description": "Oxygen requirement to keep saturations \\>95%",
                    "timeFrame": "36 weeks corrected gestational age"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Preterm infants 28-35 6/7 weeks' gestation and less than 48 hours of age who have a clinical diagnosis of respiratory distress syndrome confirmed by a chest x-ray on nasal continuous positive airway pressure (NCPAP) and FiO2 \u22650.30\n\nExclusion Criteria:\n\n* Infants will be excluded if there is a congenital anomaly or an alternative cause for respiratory distress.\n* Infants who require emergent intubation will not be enrolled in the interventions.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "maximumAge": "48 Hours",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Matthew Derrick",
                    "role": "CONTACT",
                    "phone": "18475702920",
                    "email": "mderrick@northshore.org"
                }
            ],
            "locations": [
                {
                    "facility": "Northshore University Healthsystem",
                    "status": "RECRUITING",
                    "city": "Evanston",
                    "state": "Illinois",
                    "zip": "60201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Matthew Derrick, mbbs",
                            "role": "CONTACT",
                            "phone": "847-570-2920",
                            "email": "mderrick@northshore.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.04114,
                        "lon": -87.69006
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "20084586",
                    "type": "BACKGROUND",
                    "citation": "Kribs A, Hartel C, Kattner E, Vochem M, Kuster H, Moller J, Muller D, Segerer H, Wieg C, Gebauer C, Nikischin W, Wense Av, Herting E, Roth B, Gopel W. Surfactant without intubation in preterm infants with respiratory distress: first multi-center data. Klin Padiatr. 2010 Jan-Feb;222(1):13-7. doi: 10.1055/s-0029-1241867. Epub 2010 Jan 18."
                },
                {
                    "pmid": "34902013",
                    "type": "RESULT",
                    "citation": "Dargaville PA, Kamlin COF, Orsini F, Wang X, De Paoli AG, Kanmaz Kutman HG, Cetinkaya M, Kornhauser-Cerar L, Derrick M, Ozkan H, Hulzebos CV, Schmolzer GM, Aiyappan A, Lemyre B, Kuo S, Rajadurai VS, O'Shea J, Biniwale M, Ramanathan R, Kushnir A, Bader D, Thomas MR, Chakraborty M, Buksh MJ, Bhatia R, Sullivan CL, Shinwell ES, Dyson A, Barker DP, Kugelman A, Donovan TJ, Tauscher MK, Murthy V, Ali SKM, Yossuck P, Clark HW, Soll RF, Carlin JB, Davis PG; OPTIMIST-A Trial Investigators. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial. JAMA. 2021 Dec 28;326(24):2478-2487. doi: 10.1001/jama.2021.21892."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000012128",
                    "term": "Respiratory Distress Syndrome"
                },
                {
                    "id": "D000012127",
                    "term": "Respiratory Distress Syndrome, Newborn"
                }
            ],
            "ancestors": [
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000012120",
                    "term": "Respiration Disorders"
                },
                {
                    "id": "D000007235",
                    "term": "Infant, Premature, Diseases"
                },
                {
                    "id": "D000007232",
                    "term": "Infant, Newborn, Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M14965",
                    "name": "Respiratory Distress Syndrome",
                    "asFound": "Respiratory Distress Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14964",
                    "name": "Respiratory Distress Syndrome, Newborn",
                    "asFound": "Respiratory Distress Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14957",
                    "name": "Respiration Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M25869",
                    "name": "Premature Birth",
                    "relevance": "LOW"
                },
                {
                    "id": "M10279",
                    "name": "Infant, Premature, Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10276",
                    "name": "Infant, Newborn, Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4927",
                    "name": "Respiratory Distress Syndrome, Infant",
                    "asFound": "Respiratory Distress Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "T192",
                    "name": "Acute Respiratory Distress Syndrome",
                    "asFound": "Respiratory Distress Syndrome",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011663",
                    "term": "Pulmonary Surfactants"
                }
            ],
            "ancestors": [
                {
                    "id": "D000019141",
                    "term": "Respiratory System Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14517",
                    "name": "Pulmonary Surfactants",
                    "asFound": "KRAS",
                    "relevance": "HIGH"
                },
                {
                    "id": "M231534",
                    "name": "Poractant alfa",
                    "relevance": "LOW"
                },
                {
                    "id": "M91888",
                    "name": "Calfactant",
                    "relevance": "LOW"
                },
                {
                    "id": "M21137",
                    "name": "Respiratory System Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}